Nanosphere, Inc. Logo
Nanosphere Announces Second Quarter 2011 Results
09 août 2011 16h05 HE | Nanosphere, Inc.
NORTHBROOK, Ill., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported financial...
Nanosphere, Inc. Logo
Nanosphere to Release Q2 2011 Results and Hold Investor Call on Tuesday, August 9
27 juil. 2011 17h13 HE | Nanosphere, Inc.
NORTHBROOK, Ill., July 27, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its...
Nanosphere, Inc. Logo
Nanosphere to Provide Additional Data to FDA for Verigene Clopidogrel Metabolism Nucleic Acid Test
21 juin 2011 08h00 HE | Nanosphere, Inc.
NORTHBROOK, Ill., June 21, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH) announced today it will provide additional information for its premarket approval (PMA) application following the...
Nanosphere, Inc. Logo
Nanosphere, Inc. to Present at Jefferies 2011 Global Healthcare Conference
03 juin 2011 14h24 HE | Nanosphere, Inc.
NORTHBROOK, Ill., June 3, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), announced that the company will present at the Jefferies 2011 Global Healthcare Conference on June 8. Presenting...
Nanosphere, Inc. Logo
Nanosphere to Release Positive Pilot Study Data for Ultra-Sensitive Protein Cancer Biomarkers in Conjunction With the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting
19 mai 2011 09h35 HE | Nanosphere, Inc.
NORTHBROOK, Ill., May 19, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today that it...
Nanosphere, Inc. Logo
Positive New Data Presented at the Annual Meeting of the American Urological Association Demonstrates Clinical Use for Nanosphere's Ultra-Sensitive PSA Assay
18 mai 2011 09h37 HE | Nanosphere, Inc.
NORTHBROOK, Ill., May 18, 2011 (GLOBE NEWSWIRE) -- Positive clinical studies using Nanosphere Inc.'s (Nasdaq:NSPH) Verisens™ ultra-sensitive PSA assay (research use only) were presented in...
Nanosphere, Inc. Logo
Nanosphere, Inc. Closes Common Stock Offering
13 mai 2011 14h14 HE | Nanosphere, Inc.
NORTHBROOK, Ill., May 13, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
Nanosphere, Inc. Logo
Nanosphere, Inc. Prices Public Offering of Common Stock
10 mai 2011 09h00 HE | Nanosphere, Inc.
NORTHBROOK, Ill., May 10, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
Nanosphere, Inc. Logo
Nanosphere, Inc. Announces Commencement of Public Offering of Common Stock
09 mai 2011 16h01 HE | Nanosphere, Inc.
NORTHBROOK, Ill., May 9, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
Nanosphere, Inc. Logo
Nanosphere Announces First Quarter Results
27 avr. 2011 07h30 HE | Nanosphere, Inc.
NORTHBROOK, Ill., April 27, 2011 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported...